Latest Insider Transactions at Apellis Pharmaceuticals, Inc. (APLS)
This section provides a real-time view of insider transactions for Apellis Pharmaceuticals, Inc. (APLS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Apellis Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Apellis Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2023
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Indirect |
24,000
-11.08%
|
$1,464,000
$61.13 P/Share
|
|
Nov 30
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,158
-7.73%
|
$764,532
$54.76 P/Share
|
|
Nov 30
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,158
+13.35%
|
$141,580
$10.03 P/Share
|
|
Nov 21
2023
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.82%
|
$240,000
$48.8 P/Share
|
|
Nov 17
2023
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Direct |
8,894
-6.77%
|
$435,806
$49.99 P/Share
|
|
Nov 17
2023
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.34%
|
$58,750
$47.74 P/Share
|
|
Nov 17
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.34%
|
$2,500
$2.67 P/Share
|
|
Nov 14
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+3.87%
|
$135,000
$3.76 P/Share
|
|
Nov 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.11%
|
$564,000
$47.27 P/Share
|
|
Nov 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,494
+1.59%
|
$34,988
$2.67 P/Share
|
|
Oct 23
2023
|
James George Chopas VP/Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
132
-0.4%
|
$6,072
$46.04 P/Share
|
|
Oct 23
2023
|
Mark Jeffrey De Long Chief Business & Strat Officer |
SELL
Open market or private sale
|
Direct |
131
-0.25%
|
$6,026
$46.04 P/Share
|
|
Oct 17
2023
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Indirect |
24,000
-9.97%
|
$1,176,000
$49.0 P/Share
|
|
Oct 17
2023
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.34%
|
$60,000
$48.5 P/Share
|
|
Oct 17
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.34%
|
$2,500
$2.67 P/Share
|
|
Oct 09
2023
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.11%
|
$480,000
$40.38 P/Share
|
|
Oct 09
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.69%
|
$37,000
$2.67 P/Share
|
|
Sep 19
2023
|
Cedric Francois Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
150,000
+15.72%
|
-
|
|
Sep 19
2023
|
Cedric Francois Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
150,000
-35.32%
|
-
|
|
Sep 18
2023
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.34%
|
$56,250
$45.0 P/Share
|
|
Sep 18
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.34%
|
$2,500
$2.67 P/Share
|
|
Sep 18
2023
|
Nur Nicholson Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
20,350
-14.92%
|
$895,400
$44.18 P/Share
|
|
Sep 18
2023
|
Nur Nicholson Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,719
+11.66%
|
$281,851
$29.76 P/Share
|
|
Sep 15
2023
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.34%
|
$56,250
$45.34 P/Share
|
|
Sep 15
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.34%
|
$2,500
$2.67 P/Share
|
|
Sep 14
2023
|
James George Chopas VP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+7.08%
|
-
|
|
Sep 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.12%
|
$504,000
$42.87 P/Share
|
|
Sep 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.7%
|
$37,000
$2.67 P/Share
|
|
Sep 06
2023
|
Lukas Scheibler Chief Research Officer |
SELL
Open market or private sale
|
Direct |
1,756
-2.51%
|
$75,508
$43.01 P/Share
|
|
Sep 01
2023
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
150,000
-13.34%
|
$6,300,000
$42.07 P/Share
|
|
Sep 01
2023
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300,000
+34.3%
|
$600,000
$2.67 P/Share
|
|
Aug 31
2023
|
James George Chopas VP/Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
551
-1.79%
|
$22,591
$41.23 P/Share
|
|
Aug 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.13%
|
$276,000
$23.66 P/Share
|
|
Aug 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.71%
|
$37,000
$2.67 P/Share
|
|
Jul 21
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
49,779
+11.93%
|
$99,558
$2.67 P/Share
|
|
Jul 20
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+13.6%
|
$100,000
$2.67 P/Share
|
|
Jul 17
2023
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.46%
|
$80,000
$64.79 P/Share
|
|
Jul 17
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.46%
|
$2,500
$2.67 P/Share
|
|
Jul 10
2023
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.13%
|
$1,008,000
$84.55 P/Share
|
|
Jul 10
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.72%
|
$37,000
$2.67 P/Share
|
|
Jul 03
2023
|
David O. Watson General Counsel |
SELL
Open market or private sale
|
Direct |
8,510
-9.03%
|
$757,390
$89.98 P/Share
|
|
Jul 03
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,779
-2.74%
|
$610,110
$90.31 P/Share
|
|
Jul 03
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,779
+7.43%
|
$67,790
$10.03 P/Share
|
|
Jun 28
2023
|
David O. Watson General Counsel |
BUY
Bona fide gift
|
Indirect |
12,750
+13.64%
|
-
|
|
Jun 28
2023
|
David O. Watson General Counsel |
SELL
Bona fide gift
|
Direct |
12,750
-11.91%
|
-
|
|
Jun 20
2023
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.46%
|
$110,000
$88.41 P/Share
|
|
Jun 20
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.46%
|
$2,500
$2.67 P/Share
|
|
Jun 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.14%
|
$1,092,000
$91.35 P/Share
|
|
Jun 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.73%
|
$37,000
$2.67 P/Share
|
|
Jun 05
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
69,779
-14.1%
|
$6,210,331
$89.15 P/Share
|